M. Flander

Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer.

Jorma Isola, Heikki Joensuu, Vesa Kataja, 2006, The New England journal of medicine.

Safety and efficacy results of a randomized trial comparing adjuvant toremifene and tamoxifen in postmenopausal patients with node-positive breast cancer. Finnish Breast Cancer Group.

V. Kataja, K. Holli, H. Joensuu, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Safety a nd E fficacy R esults o f a R andomized T rial Comparing A djuvant T oremifene a nd T amoxifen in P ostmenopausal P atients W ith N ode-Positive Breast C ancer

V. Kataja, K. Holli, E. Pukkala, 2000 .

Tropisetron (Navoban) in the prevention of chemotherapy-induced nausea and vomiting — the Nordic experience

M. Overgaard, M. Söderberg, T. Högberg, 1994, Supportive Care in Cancer.

5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy--a randomised study.

V. Kataja, L. Teerenhovi, M. Flander, 1993, European journal of cancer.

Comparison of ondansetron with customary treatment in the prophylaxis of nausea and emesis induced by non-cisplatin containing chemotherapy.

V. Kataja, L. Teerenhovi, M. Flander, 1993, Acta oncologica.

Treatment of primary tracheal carcinoma in Finland in 1967-1985.

P. Laippala, J. Pukander, H. Huhtala, 1993, Acta oncologica.

Combined interferon and vinblastine treatment in advanced renal cell cancer.

P. Kellokumpu-Lehtinen, M. Flander, E. Nordman, 1995, Acta oncologica.

Treatment results of nasopharyngeal cancer--a nationwide survey from Finland.

H. Joensuu, M. Kajanti, M. Flander, 1996, Acta oncologica.